Urinary proteome analysis in congenital bilateral hydronephrosis

Scandinavian Journal of Urology

Volumn 47, Issue 1, 2013, Pages 43-51

  Stodkilde, Lene ^a   Madsen, Mia Gebauer ^a,b   Palmfeldt, Johan ^b   Topcu, Sükrü Oguzkan ^a,b   Norregaard, Rikke ^a   Olsen, Lars Henning ^b   Jorgensen, Troels Munch ^b   Frokiær, Jorgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bilateral hydronephrosis; Mass spectrometry; Proteomics; Urinary biomarker

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMPLEMENT FACTOR H; FIBRINOGEN; GANGLIOSIDE GM2 ACTIVATOR PROTEIN; N ACETYLGLUCOSAMINE 6 SULFATASE; N ACETYLMURAMOYLALANINE AMIDASE; PLASMINOGEN; PREALBUMIN; PROTHROMBIN; SECRETORY COMPONENT; TAMM HORSFALL GLYCOPROTEIN; TRANSFERRIN;

ARTICLE; CLINICAL ARTICLE; CONGENITAL BILATERAL HYDRONEPHROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYDRONEPHROSIS; INFANT; MALE; MASS SPECTROMETRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS; URINARY EXCRETION; VALIDATION PROCESS;

BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; HYDRONEPHROSIS; INFANT; INFANT, NEWBORN; MALE; MASS SPECTROMETRY; NEPHROSTOMY, PERCUTANEOUS; PLASMINOGEN; PREALBUMIN; PROSPECTIVE STUDIES; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TRANSFERRIN; UROMODULIN;

EID: 84875474054     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/00365599.2012.708669     Document Type: Article

References (26)

1. Yiee J, Wilcox D. Management of fetal hydronephrosis. Pediatr Nephrol 2008;23: 347-53.
2. Scott JE, Renwick M. Urological anomalies in the Northern Region Fetal Abnormality Survey. Arch Dis Child 1993;68: 22-6.
3. Ismaili K, Hall M, Donner C, Thomas D, Vermeylen D, Avni FE. Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population. Am J Obstet Gynecol 2003;188: 242-6.
4. Helin I, Persson PH. Prenatal diagnosis of urinary tract abnormalities by ultrasound. Pediatrics 1986;78: 879-83.
5. Dhillon HK. Prenatally diagnosed hydronephrosis: the Great Ormond Street experience. Br J Urol 1998;81: 39-44.
6. Cortes D, Jorgensen TM, Rittig S, Thaarup J, Hansen A, Andersen KV, et al. Prenatal diagnosed hydronephrosis and other urological anomalies. Ugeskr Laeger 2006;168: 2544-50.
7. Thorup J, Jokela R, Cortes D, Nielsen OH. The results of 15 years of consistent strategy in treating antenatally suspected pelvi-ureteric junction obstruction. BJU Int 2003;91: 850-2.
8. Madsen MG, Norregaard R, Frokiaer J, Jorgensen TM. Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. J Pediatr Urol 2011;7: 105-12.
9. Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 2006;12: 398-400.
10. Decramer S, Rbig ZU, Wittke S, Mischak H, Bascands JL, Schanstra JP. Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol 2008;160: 127-41.
11. Drube J, Zurbig P, Schiffer E, Lau E, Ure B, Gluer S, et al. Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol 2010;25: 1673-8.
12. Mesrobian HG, Mitchell ME, See WA, Halligan BD, Carlson BE, Greene AS, et al. Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach. J Urol 2010;184: 709-14.
13. Palmfeldt J, Vang S, Stenbroen V, Pedersen CB, Christensen JH, Bross P, et al. Mitochondrial proteomics on human fibroblasts for identification of metabolic imbalance and cellular stress. Proteome Sci 2009;7: 20.
14. Carvalho PC, Fischer JS, Chen EI, Yates JR III, Barbosa VC. PatternLab for proteomics: a tool for differential shotgun proteomics. BMC Bioinformatics 2008;9: 316.
15. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279: 1477-82.
16. Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, et al. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997;8: 1889-98.
17. Schrader J, Gallimore MJ, Eisenhauer T, Isemer FE, Schoel G, Warneke G, et al. Parameters of the kallikreinkinin, coagulation and fibrinolytic systems as early indicators of kidney transplant rejection. Nephron 1988;48: 183-9.
18. Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications 1998;12: 43-60.
19. Matheson A, Willcox MD, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 2010;26: 150-71.
20. Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, et al. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991; 261: F1095-101.
21. Lynn KL, Marshall RD. Excretion of Tamm-Horsfall glycoprotein in renal disease. Clin Nephrol 1984;22: 253-7.
22. Johnstone LM, Jones CL, Walker RG, Powell HR. Tamm-Horsfall protein: are serum levels a marker for urinary tract obstruction? Pediatr Nephrol 1994;8: 689-93.
23. Kaefer M, Peters CA, Retik AB, Benacerraf BB. Increased renal echogenicity: a sonographic sign for differentiating between obstructive and nonobstructive etiologies of in utero bladder distension. J Urol 1997;158: 1026-9.
24. Churchill BM, McLorie GA, Khoury AE, Merguerian PA, Houle AM. Emergency treatment and long-term follow-up of posterior urethral valves. Urol Clin North Am 1990;17: 343-60.
25. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales L, Levin NW. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int 2003;63: 315-22.
26. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999; 13: 273-9.